We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sigmaroc Plc | LSE:SRC | London | Ordinary Share | GB00BYX5K988 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.20 | -0.30% | 66.70 | 66.70 | 67.20 | 67.50 | 66.60 | 66.90 | 1,775,922 | 16:29:56 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 580.29M | 13.53M | 0.0121 | 55.12 | 743.61M |
Hot Features
Premium
TIDMASM
London, UK, and Cambridge, MA: 20 July 2010 - Antisoma plc (LSE: ASM; USOTC:
ATSMY) will be announcing its Preliminary Results for the year ended 30 June
2010 on Thursday 29 July 2010.
Enquiries:
Daniel Elger
VP, Marketing & Communications
Antisoma plc
+44 7909 915 068
Mark Court/Lisa Baderoon/Catherine Breen
Buchanan Communications
+44 (0)20 7466 5000
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visitwww.antisoma.com for further information about
Antisoma.
[HUG#1432737]
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Antisoma plc via Thomson Reuters ONE
1 Year Sigmaroc Chart |
1 Month Sigmaroc Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
